Neuland Laboratories Ltd Quarterly Results

Q1 FY26-27 Results Summary

Revenue

The revenue stands at ₹641.58 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 17.35 per cent from ₹776.25 crore. This corresponds to a year-on-year *(YoY) growth of 119.16 per cent.

Operating Profit

Operating Profit stands at ₹222.89 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 27.48 per cent from ₹307.33 crore. This corresponds to a year-on-year *(YoY) growth of 546.25 per cent.

PBDT

PBDT stands at ₹224.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 28.21 per cent from ₹312.58 crore. This corresponds to a year-on-year *(YoY) growth of 494.28 per cent.

Profit Before Tax

Profit Before Tax stands at ₹197.84 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 31.18 per cent from ₹287.49 crore. This corresponds to a year-on-year *(YoY) growth of 1,026.01 per cent.

Net Profit

Net Profit stands at ₹147.67 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 30.56 per cent from ₹212.67 crore. This represents a 962.37 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Neuland Laboratories Ltd Earnings

CategoryQ1 FY26-27Q1 FY25-26Change %FY25-26FY24-25Change %
Total Revenue641.58292.75119.162,022.991,476.8436.98
Expenses418.69258.2662.121,448.491,153.5825.56
Other Income8.497.868.0230.1796.91-68.87
Operating Profit222.8934.49546.25604.66420.1743.91
Depreciation26.5620.1931.5591.7465.5539.95
Interest6.974.5852.1823.958.30188.55
Profit Before Tax197.8417.571026.01488.98346.3341.19
Tax50.173.671267.03128.9673.7774.81
Net Profit147.6713.90962.37364.00260.1139.94
CategoryQ1 FY26-27Q4 FY25-26Change %
Total Revenue641.58776.25-17.35
Expenses418.69468.92-10.71
Other Income8.4912.46-31.86
Operating Profit222.89307.33-27.48
Depreciation26.5625.095.86
Interest6.977.21-3.33
Profit Before Tax197.84287.49-31.18
Tax50.1774.82-32.95
Net Profit147.67212.67-30.56

Neuland Laboratories Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 16,065Edelweiss Securities10-Dec-2025

Neuland Laboratories Ltd Financial Reports

Data not available.

Neuland Laboratories Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Neuland Labs.-0.46%6.51%20.53%39.17%75.56%75.88%
Emcure Pharma1.01%4.26%12.61%21.67%35.59%38.86%
Sai Life0.63%2.49%14.03%33.46%58.42%60.69%
Wockhardt-0.93%-4.26%1.70%20.42%35.22%25.76%
Piramal Pharma1.17%3.91%24.47%22.08%30.47%12.62%
Rubicon Research0.06%7.72%14.81%74.34%110.65%163.19%
Acutaas Chemical1.26%0.15%-6.59%15.46%61.93%147.76%

Neuland Laboratories Ltd Corporate Information

Chairman & Exec. Director: D R Rao
Vice Chairman / Executive Director / WTD: D Sucheth Rao
Non Independent ED / MD / CEO / Promoter: D Saharsh Rao
Independent Non Exe. Director: Homi R Khusrokhan
Independent Non Exe. Director: P R Menon
Independent Non Exe. Director: Sugata Sircar
Independent Non Exe. Director: Pallavi Joshi Bakhru
Independent Non Exe. Director: Ravi Gopinath
Non Executive Director: Mauricio Futran
Company Sec. & Compli. Officer: Sarada Bhamidipati

Neuland Laboratories Ltd News

No More Data

More